Exosome Quantitative Proteomics Service

What Is Exosome Quantitative Proteomics?

Exosomes are nanoscale vesicles released by cells that can carry proteins and other molecular components associated with the state of the cells of origin and participate in intercellular transfer of materials and information. Exosome protein composition and abundance can change with cellular state, treatment conditions, and sample source. Quantitative comparison of exosome proteins therefore supports protein-level investigation of changes among experimental groups and screening of candidate proteins for further validation.

 

Exosome Quantitative Proteomics uses LC-MS/MS to systematically identify and relatively quantify proteins in exosome preparations, converting protein abundance across different samples into comparable quantitative information. Relative quantification approaches such as Label-Free or TMT can be selected according to the study design. Exosome isolation purity, source matrix, and preparation consistency can affect comparability, so interpretation of quantitative results should consider the sample-preparation background.

Figure 1. Exosome Origin and Protein Cargo.

When This Service Is a Good Fit

• Exosome samples from multiple experimental groups are available, and changes in relative protein abundance need to be compared.
• The study begins with source samples such as plasma, serum, urine, cerebrospinal fluid, or cell culture supernatant and requires both exosome preparation and quantitative protein analysis.
• Discovery-based protein identification and quantitative comparison are required rather than measurement of only a small number of predefined proteins.
• Exosome proteomes need to be compared across different treatment conditions, time points, cell models, or biological states.
• An appropriate relative quantification approach needs to be selected according to sample number and group design.

Exosome Quantitative Proteomics Service at MtoZ Biolabs

Based on high-resolution LC-MS/MS platforms and technologies for exosome sample processing and protein preparation, MtoZ Biolabs provides Exosome Quantitative Proteomics Service for protein identification and relative quantification of pre-isolated exosomes or source samples requiring exosome isolation. The analysis generates protein abundance matrices, between-group differential results, and quality-control information, supporting comparison of exosome protein changes across different treatment conditions, time points, or biological states.

 

An appropriate relative quantification approach can be determined according to sample source, exosome isolation status, sample number, and group design. MtoZ Biolabs can integrate exosome isolation/purification, protein extraction and digestion, LC-MS/MS acquisition, and quantitative data processing. Extended analyses such as functional annotation are arranged according to the confirmed analysis plan.

Analysis Workflow

1. Sample and Study Design Evaluation

Confirm the sample source, exosome isolation status, sample number, available amount, group design, and quantitative objectives.

 

2. Exosome Preparation and Sample Evaluation

Perform exosome isolation/purification from source samples as required by the study. For pre-isolated exosomes, evaluate the preparation method, buffer system, and sample condition.

 

3. Protein Extraction and Digestion

Extract proteins from exosome preparations and perform enzymatic digestion to obtain peptides suitable for LC-MS/MS analysis.

 

4. Quantification Strategy and LC-MS/MS Acquisition

Select a relative quantification approach such as Label-Free or TMT according to the study design, match the approach with an appropriate mass spectrometry acquisition mode, and perform high-resolution LC-MS/MS acquisition.

 

5. Protein Identification and Relative Quantification

Complete peptide and protein identification and generate comparable relative protein abundance data across samples.

 

6. Between-Group Comparison and Result Organization

Perform quality control, differential protein statistics, and result organization according to the experimental groups. Extended analyses are provided according to the analysis plan.

Sample Submission Suggestions

Sample Type	Suggested Starting Input	Key Information
Plasma / Serum	1 mL	Collection and storage conditions, group design
Cell Culture Supernatant	50 mL	Culture conditions, collection method, group design
Urine	10 mL	Collection and preprocessing, storage, group design
Cerebrospinal Fluid (CSF)	10 mL	Collection and processing conditions, storage, group design
Semen / Seminal Plasma	0.5 mL	Collection conditions, storage, group design
Animal Tissue	3 g	Tissue source, storage conditions, group design
Pre-Isolated Exosomes	50 μL	Isolation method, buffer system, storage conditions

Sample storage and transportation conditions should remain as consistent as possible, and repeated freeze-thaw cycles should be avoided. Different experimental groups should use consistent collection, exosome preparation, and sample-processing conditions whenever possible.

Why Choose MtoZ Biolabs?

1. High-Resolution Mass Spectrometry

High-resolution LC-MS/MS supports exosome protein identification and relative quantification, providing the data basis for protein abundance comparison across samples.

 

2. Low-Input Sample Analysis

Sample processing and peptide preparation can be optimized according to the available material when exosome protein amounts are limited, helping reduce sample loss during preparation.

 

3. One-Stop Service

Analysis can begin with source samples or pre-isolated exosomes and can integrate exosome preparation, protein processing, LC-MS/MS, and quantitative data analysis.

 

4. Flexible Quantification Design

Relative quantification approaches such as Label-Free or TMT can be selected according to sample number, group design, and comparison objectives and matched with appropriate mass spectrometry acquisition conditions.

Applications

1. Exosome Biology Research

Compare exosome protein composition and abundance across different biological states for studies of exosome biology and intercellular communication.

 

2. Disease-Related Research

Analyze exosome protein differences among disease models, control groups, or other research groups to provide quantitative data for disease-related protein research.

 

3. Drug and Treatment Response

Compare changes in exosome proteins before and after drug treatment, stimulation, or other experimental interventions.

 

4. Cell Culture Exosome Studies

Analyze protein changes in exosomes derived from cell culture supernatants under different cell lines, culture conditions, genetic manipulations, or experimental conditions.

 

5. Biofluid Exosome Research

Perform quantitative comparison of exosome proteins from source samples such as plasma, serum, urine, or cerebrospinal fluid.

 

6. Biomarker Candidate Research

Screen candidate proteins from exosome protein differences among experimental groups to provide candidates for subsequent validation and further research.

Deliverables

1. Sample processing, exosome preparation, and quantitative experimental workflow information, according to the project scope.

2. Liquid chromatography and mass spectrometry acquisition parameters.

3. Raw mass spectrometry data.

4. Peptide and protein identification results.

5. Relative protein quantification matrix and quality-control results.

6. Between-group differential protein statistics and related visualization results.

7. Functional annotation or pathway analysis results (if applicable).

8. Processed data files and analysis report.

FAQ

Q1: Can high-abundance plasma proteins affect serum- or plasma-derived exosome proteomics?

Yes. High-abundance serum or plasma proteins may co-isolate during exosome preparation and affect the detection of low-abundance proteins. Results should therefore be interpreted together with the isolation method and sample purity.

 

Q2: Can conventional quantitative proteomics distinguish exosome membrane proteins from proteins inside the vesicle?

No. Conventional exosome quantitative proteomics analyzes the entire exosome preparation. Additional localization experiments are required to determine whether a protein is located on the membrane surface or inside the vesicle.

 

Q3: How should protein abundance be compared when exosome numbers differ substantially among samples?

A consistent input or normalization basis should be defined during study design, such as source sample volume, exosome particle number, or protein amount. The selected basis should match the research objective and sample conditions.

 

Q4: Can all low-abundance exosome proteins be quantified reliably?

No guarantee can be made. Quantification of low-abundance proteins is affected by sample amount, background complexity, and signal coverage, so the number of proteins with stable quantitative values may be lower than the total number of identified proteins.

 

Q5: How many biological replicates are required for exosome quantitative proteomics?

There is no single fixed number. Biological replicates should be determined according to the study groups, sample heterogeneity, and statistical objectives. Technical replicates cannot replace independent biological replicates.

 

Q6: Can discovery-based exosome quantitative proteomics results be followed by targeted validation?

Yes. Candidate proteins can be selected from the quantitative results, followed by evaluation of PRM/MRM or antibody-based methods for targeted validation.

 

Start Your Project with MtoZ Biolabs

For Exosome Quantitative Proteomics analysis, provide the sample source, exosome isolation status, sample number, group design, available sample amount, and primary comparison objectives. The MtoZ Biolabs technical team will first evaluate the sample conditions and study design, confirm analytical feasibility and an appropriate quantification approach, and then arrange sample processing, mass spectrometry acquisition, and subsequent analysis.